Fat Grafting in Corona CA
As we grow older our face become more and more affected by the sun, gravity and use of expression muscles (chewing, smiling, etc). Deep tissues loose the ability to maintain a young look and expression marks appear on our faces. Fat grafting can help you fill the defects and regain younger appearance. It can be used to fill expression folds, sunken checks, scars and lips. This procedure is not sufficient to treat deep defects like multiple grooves around the mouse of heavy smokers. It can be done as isolated treatment or as a combination with laser, facelift and botox.
During the procedure the surgeon performs a liposuction from various body parts like thighs, tummy and buttocks and then injects the fat into selected areas needs to be filled. After disinfection of the donor and recipient areas, they are being sedated using local anesthetics. Sedative drugs also can be used, if so you may need an escort to avoid driving under their influence. For liposuction the surgeon uses wide needle or canola. After a short treatment the fat is injected to the desired site. The recipient area is usually bandaged. In order to fill sunken chicks often over filling is required because of absorption process of some of the fat injected. This can make your face appear over swollen immediately after the operation.
If the area treated is extensive it is advisable to restrain from activities after the treatment. Although most of the patients can go back to their daily activities right away. There might be redness, swelling and small hemorrhages around both the donor and the recipient sites. The severity of those symptoms usually depends on the magnitude of the procedure. It is advisable to avoid sun exposure until the above disappear (after approximately 48 hours). There is no limitation to use make-up. The swelling can last for weeks especially if the area is large. Every operation has its ricks. The fat being taken from the patient's body doesn't cause allergic responses. There is a small chance of infection.
You must remember that the effect of the injection is only temporary. Due to their biological nature the injected materials disassemble by the body. The duration of the effect depends on genetics, age, skin quality, life style and the area being filled. There are selected cases where the results lasted for a year, but in most cases half of the effect disappears after 3-6 month.
More Corona info...
Corona Sleep
Best Western Kings Inn, 1084 Pomona Road, ? +1 951 734-4241 (toll free: +1 800 892-5464, fax: +1 951 279-5371), [1].
Motel 6, 200 North Lincoln Avenue, ? +1 951 735-6408 (fax: +1 951 340-2123), [2].
Corona Get out This article is an outline and needs more content. It has a template, but there is not enough information present. Please plunge forward and help it grow!
Plastic Surgery News...
- Intercare Insurance Solutions, a leader in innovative benefits consulting and services, announced it hosted a breakfast seminar where San Francisco Bay Area employers learned about a unique approach to health benefits planning that delivers an ROI on health care dollars of approximately 5:1.
- The Southwest Oncology Group Study 9626 has examined the efficacy of megesterol acetate (MA) in treating hot flushes in women with breast cancer. It involved 288 patients (2 ineligible) with T1-3, N0-1, M0 breast cancer who had completed surgery and chemotherapy and at least 4 months of tamoxifen (if prescribed). They had to have experienced at least 10 hot flushes of any severity or at least five severe episodes per week. Overall, 85% were on tamoxifen, 40% had over 63 hot flushes per week and 75% had vasomotor symptoms for 6 months or longer. They were randomised to receive placebo (n=101), MA 20 mg (n=92), or MA 40 mg (n=93) for 3 months. Success at 3 months was defined as completion of treatment with a 75% or greater reduction in hot flushes from baseline. Another 3 months of treatment was given in the same blinded arm if success was achieved, and in those who were not classified as successfully treated, open-label MA 20 mg was added to blinded study drug and continued for 3 months.
Success at 3 months was reported in:
• 14% on placebo
• 65% on 20 mg (p < 0.0001 vs placebo)
• 48% on 40 mg (p < 0.0001 vs placebo)
In addition, most successes at 3 months were maintained at 6 months (77% on 20 mg and 81% on 40 mg). There was however no significant impact on other menopausal symptoms. In physicians’ assessment of toxicity experienced by patients up to and including the 3-month evaluation, oedema and weight gain was reported in the placebo arm; fatigue in the MA20 arm; and depression, fatigue, nausea, and weight gain in the MA40 arm. There were no statistically significant differences by treatment arm for any toxicities.
The researchers concluded that MA at the preferred dose of 20mg was successful in alleviating vasomotor symptoms in breast cancer survivors with durable results at 6 months. They suggest that “this treatment could be considered in women refractory to non-hormonal therapies whose symptom status is impaired by the vasomotor symptoms and who have been informed of the risk and benefit of such treatment by their physician.”